Abstract
Background: Gastrointestinal stromal tumours (GISTs) are the commonest mesenchymal tumours of the gastrointestinal tract, most frequently occurring in the stomach. While tyrosine kinase inhibitors have improved outcomes for patients with advanced or high risk GISTs, surgical resection remains the mainstay of treatment for localised disease. A minimally-invasive transgastric approach may be particularly useful for tumours in close proximity to the oesophagogastric junction.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.